162401-32-3 Roflumilast, China 162401-32-3 Roflumilast Manufacturers, China 162401-32-3 Roflumilast Suppliers

Details for Roflumilast

Roflumilast

Category :	Pharmaceuticals and Biochemicals
CAS NO :	162401-32-3
EC NO :
MF :	C₁₇H₁₄Cl₂F₂N₂O₃
MW :	403.2075
Product description :	Product name:Roflumilast Chemical name:3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide CAS No.:162401-32-3 Specification:99.0%HPLC Molecular Formula:C17H14Cl2F2N2O3 Molecular Weight:403.21 Appearance: white powder Usage:On March 1,2011, the FDA approved the chronic obstructive pneumonia drug Daliresp (roflumilast), the drug used daily, can reduce asthma attack frequency or mitigate serious chronic obstructive pneumonia (COPD) symptoms.Roflumilast is a new category of COPD drug, phosphodiesterase - 4 (PDE - 4) inhibitors. Can be used among patients with serious COPD cough and bronchial symptom related much sputum, does not apply to mild emphysema.
Synonyms :	3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;B 9302-107;BY 217;BYK 20869;Daxas;3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide;N-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide;
Molecular Structure :